ASBPW
Aspire-Lakewood Holdings, Inc. SEC filings
Every EDGAR filing for Aspire-Lakewood Holdings, Inc. (ASBPW), newest first, with AI summaries and stories.
- Ticker
- ASBPW
- CIK
- 1847345
- Sector
- Biotech and pharma
- Latest filing
- Sep 29
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KAspire-Lakewood Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINESCHEDULE 13G/AAspire Biopharma Holdings, Inc.ASBPWLIVE Ownership stake disclosure by HIGHBRIDGE CAPITAL MANAGEMENT LLC (amended)
HIGHBRIDGE CAPITAL MANAGEMENT LLC, filed by
NOTABLE10-QAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINESCHEDULE 13GAspire Biopharma Holdings, Inc.ASBPWLIVE Ownership stake disclosure by Gary Shirinyan
Gary Shirinyan, filed by
ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINESCHEDULE 13G/AAspire Biopharma Holdings, Inc.ASBPWLIVE Ownership stake disclosure by Lance Friedman (amended)
Lance Friedman, filed by
ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINESCHEDULE 13GAspire Biopharma Holdings, Inc.ASBPWLIVE Ownership stake disclosure by Alois Ryan Rubenbauer III
Alois Ryan Rubenbauer III, filed by
ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE NOTABLE10-QAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINESCHEDULE 13GAspire Biopharma Holdings, Inc.ASBPWLIVE Ownership stake disclosure by HIGHBRIDGE CAPITAL MANAGEMENT LLC
HIGHBRIDGE CAPITAL MANAGEMENT LLC, filed by
ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINESCHEDULE 13G/AAspire Biopharma Holdings, Inc.ASBPWLIVE Ownership stake disclosure by ARDSLEY ADVISORY PARTNERS LP (amended)
ARDSLEY ADVISORY PARTNERS LP, filed by
ROUTINEDEFR14AAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINEDEF 14AAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINEPRE 14AAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-K/AAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINEEFFECTAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINES-1/AAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE10-K/AAspire Biopharma Holdings, Inc.ASBPWLIVE NOTABLE10-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINEDEF 14AAspire Biopharma Holdings, Inc.ASBPWLIVE NOTABLES-1Aspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINEPRE 14AAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINESCHEDULE 13GAspire Biopharma Holdings, Inc.ASBPWLIVE Ownership stake disclosure by ARDSLEY ADVISORY PARTNERS LP
ARDSLEY ADVISORY PARTNERS LP, filed by
ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINEEFFECTAspire Biopharma Holdings, Inc.ASBPWLIVE NOTABLES-1Aspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE10-Q/AAspire Biopharma Holdings, Inc.ASBPWLIVE NOTABLE10-QAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE ROUTINE8-KAspire Biopharma Holdings, Inc.ASBPWLIVE